These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1351044)

  • 21. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
    Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer.
    Knyazev PG; Imyanitov EN; Chernitsa OI; Nikiforova IF
    Int J Cancer; 1993 Jan; 53(1):11-6. PubMed ID: 8416194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and molecular heterogeneity of breast cancer cells.
    Callahan R; Cropp C; Merlo GR; Diella F; Venesio T; Lidereau R; Cappa AP; Lisicia DS
    Clin Chim Acta; 1993 Jul; 217(1):63-73. PubMed ID: 8222284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensive and divergent chromosomal losses in squamous and spindle-cell components of esophageal sarcomatoid carcinoma.
    Kwon MS; Hong SJ; Cho HA; Ahn GH; Lee SS; Lee KY; Rhyu MG
    Virchows Arch; 2003 Nov; 443(5):635-42. PubMed ID: 12928897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
    Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
    Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity for allelic loss in human breast cancer.
    Chen LC; Kurisu W; Ljung BM; Goldman ES; Moore D; Smith HS
    J Natl Cancer Inst; 1992 Apr; 84(7):506-10. PubMed ID: 1312176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
    Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
    Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity studies in squamous cell carcinomas of the head and neck.
    Ransom DT; Leonard JH; Kearsley JH; Turbett GR; Heel K; Sosars V; Hayward NK; Bishop JF
    Head Neck; 1996; 18(3):248-53. PubMed ID: 8860766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
    Thorlacius S; Jonasdottir O; Eyfjord JE
    Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
    Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
    Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
    Tsuda H; Fukutomi T; Hirohashi S
    Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Amplification of the erbb-2 (Her-2/NEU), erbb-1 (HER-1) and c-myc oncogenes is often combined with the deletion of the short arm of chromosome 17 in human carcinoma].
    Imianitov EN; Chernitsa OI; Nikiforova IF; Serova OM; Sokolov SI; Laur OIu; Togo AV; Kniazev PG
    Mol Biol (Mosk); 1993; 27(4):888-94. PubMed ID: 8103188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressor genes in breast cancer: an overview.
    Steeg PS
    Cancer Treat Res; 1992; 61():45-57. PubMed ID: 1360244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in human breast cancer: an overview.
    Callahan R; Campbell G
    J Natl Cancer Inst; 1989 Dec; 81(23):1780-6. PubMed ID: 2685334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic markers as prognostic indicators in breast cancer.
    Wolman SR; Pauley RJ; Mohamed AN; Dawson PJ; Visscher DW; Sarkar FH
    Cancer; 1992 Sep; 70(6 Suppl):1765-74. PubMed ID: 1355402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.
    Yokota J; Wada M; Shimosato Y; Terada M; Sugimura T
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9252-6. PubMed ID: 2892196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
    Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity at chromosome 1p in human breast cancer.
    Ragnarsson G; Sigurdsson A; Eiriksdottir G; Barkardottir R; Jonasson J; Ingvarsson S
    Int J Oncol; 1996 Oct; 9(4):731-6. PubMed ID: 21541576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy.
    Lizard-Nacol S; Lidereau R; Collin F; Arnal M; Hahnel L; Roignot P; Cuisenier J; Guerrin J
    Cancer Res; 1995 Oct; 55(19):4416-9. PubMed ID: 7671254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations.
    Harada Y; Katagiri T; Ito I; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer; 1994 Oct; 74(8):2281-6. PubMed ID: 7922980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.